Secondary analyses were performed on data from 259 subjects with major depressive disorder with psychotic features ( DSM-IV-TR ) aged 18-93 years in the double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression ( Study of Pharmacotherapy of Psychotic Depression ) .